Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Your Article Summary
Vanoxerine, a New Drug for Terminating Atrial Fibrillation and Flutter
Journal of Cardiovascular Electrophysiology, 10/28/09
Matsumoto N et al. – Vanoxerine effectively terminated induced, sustained AF and AFL in the canine SP model, and produced insignificant or minimal changes in refractoriness, conduction time, or stimulus threshold, consistent with little proarrhythmic risk.
Related Articles
Catheter Ablation of Supraventricular Arrhythmias and Atrial Fibrillation
American Family Physician, 11/12/09
Relevance Score: 90%
Glucocorticoid Use and Risk of Atrial Fibrillation or Flutter
Archives of Internal Medicine, 10/14/09
Relevance Score: 90%
Anticoagulant Management in Patients with Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09
Relevance Score: 89%
Patient Characteristics Associated With the Choice of Triple Antithrombotic Therapy in Acute Coronary Syndromes
The American Journal of Cardiology, 10/22/09
Relevance Score: 88%
Outcomes in Patients Requiring Cardioversion Following Catheter Ablation of Atrial Fibrillation
Journal of Cardiovascular Electrophysiology, 10/01/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Linezolid in the Treatment of Multidrug-Resistant Tuberculosis
Clinical Infectious Diseases, 12/07/09
Currently approved prophylactic HPV vaccines
Expert Review of Vaccines, 12/07/09
Paracetamol plus ibuprofen reduced fever in young children faster than paracetamol alone but not ibuprofen alone
Evidence-Based Medicine, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


